Neurocrine Biosciences (NBIX) Gross Margin Growth (3y) (2020 - 2026)
Neurocrine Biosciences (NBIX) Gross Margin Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 631.00 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 106.00 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -675.00 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 7,053.00 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 33.00 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -344.00 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -37,361.00 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1,517.00 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 3,557.00 |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | 622.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.00 |
| Dec 31, 2025 | -32.00 |
| Sep 30, 2025 | -19.00 |
| Jun 30, 2025 | 2,236.00 |
| Mar 31, 2025 | -13.00 |
| Dec 31, 2024 | -17.00 |
| Sep 30, 2024 | 13.00 |
| Jun 30, 2024 | -49.00 |
| Mar 31, 2024 | -23.00 |
| Dec 31, 2023 | -48.00 |
| Sep 30, 2023 | -120.00 |
| Jun 30, 2023 | -175.00 |
| Mar 31, 2023 | -114.00 |
| Dec 31, 2022 | -84.00 |
| Sep 30, 2022 | -58.00 |
| Jun 30, 2022 | -2,313.00 |
| Mar 31, 2022 | -69.00 |
| Dec 31, 2021 | -14.00 |
| Sep 30, 2021 | -40.00 |
| Jun 30, 2021 | -19.00 |